Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Cagrilintide for Sale > Mazdutide Mots-C Cagrisema Cagrilintide 99% Purity Peptide for Lose Weight
Mazdutide Mots-C Cagrisema Cagrilintide 99% Purity Peptide for Lose Weight buy - large image1
Mazdutide Mots-C Cagrisema Cagrilintide 99% Purity Peptide for Lose Weight buy - image1
Mazdutide Mots-C Cagrisema Cagrilintide 99% Purity Peptide for Lose Weight buy - image2
Mazdutide Mots-C Cagrisema Cagrilintide 99% Purity Peptide for Lose Weight buy - image3
Mazdutide Mots-C Cagrisema Cagrilintide 99% Purity Peptide for Lose Weight buy - image4
Mazdutide Mots-C Cagrisema Cagrilintide 99% Purity Peptide for Lose Weight buy - image5
Mazdutide Mots-C Cagrisema Cagrilintide 99% Purity Peptide for Lose Weight buy - image6

Mazdutide Mots-C Cagrisema Cagrilintide 99% Purity Peptide for Lose Weight

62 Inquiries

Unit Price:

$150-160/MT FOB

Get Latest Price
CAS No.:

1415456-99-3

Grade:

Pharmaceutical Grade

Content:

99%

Port:

gz

Packaging:

5mg 10mg ,10vials/box

Price valid (until):

2028-12-31

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Retatrutide,Tirzepatide,GHK-Cu,TB500,Nad+

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


    Description  


    Sales manager:Nora
    whatsapp:+12817797656
    Email:lisa@qtsbio.com


    Product Name Retatrutide
    Appearance White powder
    CAS No. 1415456-99-3
    Application Weight Loss


       Product Function


    Cagrilintide is a promising long-acting acylated amylin analog designed to address metabolic health challenges, with robust efficacy in obesity management and type 2 diabetes (T2D) support. Its unique mechanism of action and clinical performance make it a valuable candidate in metabolic care.

    1. Powerful Weight Management

    As a dual agonist of amylin receptors (AMYR) and calcitonin receptors (CTR), cagrilintide targets key pathways regulating appetite and energy balance:

    • Appetite suppression: It acts on central nervous system receptors to reduce hunger signals, leading to decreased calorie intake.

    • Clinical outcomes: In Phase II trials, weekly subcutaneous s of cagrilintide resulted in 6–10.8% average weight loss in obese patients over 26 weeks. When combined with semaglutide (a GLP-1 receptor agonist), the effect is enhanced, with even greater weight reduction observed in both obese individuals and those with T2D.

    2. Support for Glycemic Control

    While primarily recognized for weight loss, cagrilintide contributes to blood sugar regulation:

    • It complements natural metabolic processes by influencing postprandial glucose responses and improving sensitivity.

    • In T2D patients, it helps maintain stable blood glucose levels, supporting overall metabolic health when used as part of a comprehensive treatment plan.

    3. Well-Tolerated & Convenient Administration

    Cagrilintide is formulated for once-weekly subcutaneous , offering convenience and adherence for patients. Its long-acting profile ensures sustained therapeutic effects, aligning with modern demands for user-friendly metabolic therapies.

    With its dual focus on weight management and metabolic support, cagrilintide represents a significant advancement in addressing the interconnected challenges of obesity and type 2 diabetes, making it a compelling option for healthcare providers and patients worldwide.


    Product Application


      • Research material for studies on immune regulation and cellular immune function.

      • Used in investigations of thymic peptides, bioactive peptides, and related biological mechanisms.

      • Applied in biotechnology, life science research, and functional ingredient development.

    FAQ

    1. How to make an order?
    Send me message and let me know what you need with quantity , then i will calculate to you

    2. What's the lead time and shipping ways?
    We will delivery to the package by UPS, FEDEX, DHL paket and YANWEN express to you after receive your payment, it would take around 5-15 days to your address.

    3. How do i keep the peptides when i receive it ?
    Peptides in the form of lyophilized powder can be transported at room temperature by vacuum packaging, while polypeptides in the dissolved state need to be refrigerated at 2°C - 8°C. For long-term storage, peptides should be stored in the form of lyophilized powder store at -20°C or -80°C in a sealed container with desiccant, which can avoid the degradation of peptides to the greatest extent.

    4. What's the payment methods?
    We could accept pay through Wise, Bank Transfer, Alipay USDT and BTC.



       Why choose us?   


    Shop High-Quality Thymulin Peptide for Research on T Lymphocyte Differentiation and Maturation-Detailed Image 1 Shop High-Quality Thymulin Peptide for Research on T Lymphocyte Differentiation and Maturation-Detailed Image 2 Shop High-Quality Thymulin Peptide for Research on T Lymphocyte Differentiation and Maturation-Detailed Image 3

    Our Advantages.

    1.High quality with competitive price.

    2. All purity>99%.

    3. We are manufacturer and can provide high quality products with factory price.

    4. Reliable delivery: Timely and efficient transportation to ensure that your production schedule is met.

    ECHEMI Editorial Reference

    Cagrilintide is a long-acting amylin analog and peptide-based pharmaceutical ingredient. As a pharmaceutical raw material, Cagrilintide is characterized by its peptide structure and amylin receptor activity. It is suitable for API research, analytical testing, pharmaceutical development, and related manufacturing processes.

    Basic Info
    Product Name:

    Cagrilintide

    Other Name:

    Cagrilintide;Cargliptin;Caglitide;Cagrilintide acetate;Cagrilintide peptide;Cagrilintide 5mg 10mg 15mg;Cagrilintide(Acetate form);Kagliptin

    CAS No.:

    1415456-99-3

    Molecular Weight:

    0

    EC Number:

    206-141-6

    Color/Form:

    White to off-white

    Research
    Class:

    Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)

    Status:

    Investigational — Phase 3 (REDEFINE program, CagriSema combination)

    Mechanism:

    A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity. Administered once weekly.

    Activity note:

    Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.

    Source:

    MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.

    Clinical Development:

    NCT05249895; NCT05249882

    References
    PubChem:

    PubChem

    Disclaimer:

    Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Retatrutide,Tirzepatide,GHK-Cu,TB500,Nad+

    Location:

    Beijing

    Year of Establishment:

    2026

  • Inquiry History
    62 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Cagrilintide

    25 MG Aug 31, 2026
    United States

    Cagrlintide

    1 MT Jul 31, 2026
    United Kingdom

    cagrilintrude

    20 MG Jul 21, 2026
    United States

    Cagrilintide

    1 KG Jul 17, 2026
    United States

    Cagrilintide

    30 MG May 26, 2026
    United Kingdom

    CAGRILLINTED

    10  May 3, 2026
    Hongkong, China

    Cagrilintide

    100 MG Apr 22, 2026
    United Kingdom

    Cagrilintide

    1 KG Apr 14, 2026
    Ireland

    Cagrilintide

    10 PCS Apr 14, 2026
    United States

    Cargrilintide

    10 MG Mar 19, 2026
    United Kingdom

    cagrilintide

    10 MG Feb 18, 2026
    China

    CagriSema cagrilintide 2.5mg+Samaglutide2.5mg

    10 MG Jan 26, 2026
    South Korea

    Cagrilintide

    500 MG Jan 21, 2026
    Pakistan

    cagrilintide

    1 KG Dec 26, 2025
    United States

    Cagrilintide

    20 MG Dec 19, 2025
    United Kingdom

    Cagrilintide

    100 MG Dec 10, 2025
    Canada

    All peptides

    1001 MT Nov 12, 2025
    United States

    Cagrilintide

    10 MG Oct 13, 2024
    United States

    Cagrilintide

    1 MG Jun 3, 2024
    Australia

    Cagrilintide

    20 MG Aug 17, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.